PEPG
PepGen Inc.
0.00 (0.00%)2.90USD242K成交股數201M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 2K |
| 近 180 天 淨額 | −2K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 05-26 | Kasraian Kasra | Chief Technical Officer | S 公開市場賣出 | 1.2K | 1.41 | 2K | 50.1K | SEC |
| 2026-03-04 | 03-06 | McArthur James G | President and CEO | S 公開市場賣出 | 131 | 6.33 | 829.23 | 296K | SEC |
| 2026-03-04 | 03-06 | McArthur James G | President and CEO | S 公開市場賣出 | 5.1K | 6.23 | 32K | 296K | SEC |
| 2026-03-04 | 03-06 | Donnelly Noel | Chief Financial Officer | S 公開市場賣出 | 2.0K | 6.23 | 13K | 112K | SEC |
| 2026-03-04 | 03-06 | Donnelly Noel | Chief Financial Officer | S 公開市場賣出 | 52 | 6.33 | 329.16 | 112K | SEC |
| 2026-03-04 | 03-06 | STRECK PAUL | EVP, Head of R&D | S 公開市場賣出 | 1.8K | 6.23 | 11K | 76.3K | SEC |
| 2026-03-04 | 03-06 | STRECK PAUL | EVP, Head of R&D | S 公開市場賣出 | 47 | 6.29 | 295.63 | 76.2K | SEC |
| 2026-03-01 | 03-02 | McArthur James G | President and CEO | A 獲配股票 | 188K | – | – | 302K | SEC |
| 2026-03-01 | 03-02 | Donnelly Noel | Chief Financial Officer | A 獲配股票 | 76.8K | – | – | 114K | SEC |
| 2026-03-01 | 03-02 | STRECK PAUL | EVP, Head of R&D | A 獲配股票 | 50.3K | – | – | 78.1K | SEC |
| 2026-03-01 | 03-02 | Kasraian Kasra | Chief Technical Officer | A 獲配股票 | 34.6K | – | – | 51.3K | SEC |
| 2026-03-01 | 03-02 | Vittiglio Joseph | Chief Business & Legal Officer | A 獲配股票 | 30.7K | – | – | 65.7K | SEC |
| 2025-12-08 | 12-10 | Vittiglio Joseph | Chief Business & Legal Officer | A 獲配股票 | 35.0K | – | – | 35.0K | SEC |
| 2025-09-30 | 10-01 | Oxford Science Enterprises plc | Other | P 公開市場買進 | 200K | 3.20 | 640K | 5.0M | SEC |
| 2025-09-26 | 09-30 | Kolchinsky Peter | Director,TenPercentOwner | P 公開市場買進 | 9.4M | 3.20 | 30.0M | 18.6M | SEC |
| 2025-09-26 | 09-30 | RA Capital Healthcare Fund LP | Director,TenPercentOwner | P 公開市場買進 | 9.4M | 3.20 | 30.0M | 18.6M | SEC |
| 2025-09-26 | 09-30 | RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | P 公開市場買進 | 9.4M | 3.20 | 30.0M | 18.6M | SEC |
| 2025-09-26 | 09-30 | Shah Rajeev M. | Director,TenPercentOwner | P 公開市場買進 | 9.4M | 3.20 | 30.0M | 18.6M | SEC |
| 2025-09-26 | 09-30 | RA Capital Nexus Fund II, L.P. | Director | P 公開市場買進 | 9.4M | 3.20 | 30.0M | 18.6M | SEC |
| 2025-05-30 | 06-02 | STRECK PAUL | EVP, Head of R&D | P 公開市場買進 | 8.4K | 1.24 | 10K | 27.8K | SEC |
| 2025-05-20 | 05-21 | Kasraian Kasra | Chief Technical Officer | A 獲配股票 | 16.8K | – | – | 16.8K | SEC |
| 2025-04-17 | 04-22 | McArthur James G | President and CEO | P 公開市場買進 | 10.0K | 1.36 | 14K | 114K | SEC |
| 2025-04-08 | 04-09 | McArthur James G | President and CEO | P 公開市場買進 | 41.5K | 1.15 | 48K | 104K | SEC |
| 2025-03-03 | 03-05 | DeLena Mary Beth | General Counsel | A 獲配股票 | 13.4K | – | – | 15.0K | SEC |
| 2025-03-03 | 03-05 | McArthur James G | President and CEO | A 獲配股票 | 60.7K | – | – | 62.4K | SEC |
| 2025-03-03 | 03-05 | STRECK PAUL | EVP, Head of R&D | A 獲配股票 | 19.4K | – | – | 19.4K | SEC |
| 2025-03-03 | 03-05 | Donnelly Noel | Chief Financial Officer | A 獲配股票 | 23.3K | – | – | 25.0K | SEC |
| 2025-02-26 | 02-26 | Donnelly Noel | Chief Financial Officer | S 公開市場賣出 | 1.5K | 1.68 | 3K | 1.7K | SEC |
| 2025-02-26 | 02-26 | DeLena Mary Beth | General Counsel | S 公開市場賣出 | 1.4K | 1.68 | 2K | 1.6K | SEC |
| 2025-02-24 | 02-26 | Donnelly Noel | Chief Financial Officer | A 獲配股票 | 3.2K | – | – | 3.2K | SEC |
| 2025-02-24 | 02-26 | DeLena Mary Beth | General Counsel | A 獲配股票 | 3.0K | – | – | 3.0K | SEC |
| 2024-07-25 | 07-26 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 7.6K | 10.21 | 77K | 7.6K | SEC |
| 2024-07-25 | 07-26 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 7.6K | 18.06 | 137K | 0 | SEC |
| 2024-07-24 | 07-26 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 201 | 18.01 | 4K | 0 | SEC |
| 2024-07-24 | 07-26 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 201 | 10.21 | 2K | 201 | SEC |
| 2024-07-18 | 07-19 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 12.6K | 10.21 | 129K | 12.6K | SEC |
| 2024-07-18 | 07-19 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 12.6K | 18.20 | 230K | 0 | SEC |
| 2024-07-16 | 07-16 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 5.9K | 10.21 | 60K | 5.9K | SEC |
| 2024-07-16 | 07-16 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.9K | 18.00 | 106K | 0 | SEC |
| 2024-07-12 | 07-16 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 3.3K | 10.21 | 34K | 3.3K | SEC |
| 2024-07-12 | 07-16 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 3.3K | 18.04 | 59K | 0 | SEC |
| 2024-07-02 | 07-03 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 37 | 10.21 | 377.77 | 37 | SEC |
| 2024-07-02 | 07-03 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 37 | 18.07 | 668.59 | 0 | SEC |
| 2024-07-01 | 07-03 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 875 | 10.21 | 9K | 875 | SEC |
| 2024-07-01 | 07-03 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 875 | 18.01 | 16K | 0 | SEC |
| 2024-06-24 | 06-26 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 9.3K | 10.21 | 95K | 9.3K | SEC |
| 2024-06-24 | 06-26 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.3K | 18.19 | 168K | 0 | SEC |
| 2024-06-12 | 06-13 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 1.1K | 10.21 | 11K | 1.1K | SEC |
| 2024-06-12 | 06-13 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 1.1K | 18.06 | 20K | 0 | SEC |
| 2024-06-11 | 06-13 | Mellion Michelle L | Chief Medical Officer | M 選擇權執行 | 500 | 10.21 | 5K | 500 | SEC |
| 2024-06-11 | 06-13 | Mellion Michelle L | Chief Medical Officer | S 公開市場賣出(10b5-1) | 500 | 18.04 | 9K | 0 | SEC |
| 2024-06-06 | 06-07 | Mellion Michelle L | SVP, Clinical Development | M 選擇權執行 | 1.4K | 10.21 | 14K | 1.4K | SEC |
| 2024-06-06 | 06-07 | Mellion Michelle L | SVP, Clinical Development | S 公開市場賣出(10b5-1) | 1.4K | 18.00 | 25K | 0 | SEC |
| 2024-06-05 | 06-07 | Mellion Michelle L | SVP, Clinical Development | M 選擇權執行 | 7.2K | 10.21 | 74K | 7.2K | SEC |
| 2024-06-05 | 06-07 | Mellion Michelle L | SVP, Clinical Development | S 公開市場賣出(10b5-1) | 7.2K | 18.09 | 131K | 0 | SEC |
| 2024-05-17 | 05-17 | Svenstrup Niels | SVP, Chem. Mfg & Controls | S 公開市場賣出 | 10.0K | 13.41 | 134K | 0 | SEC |
| 2024-02-09 | 02-13 | RA Capital Healthcare Fund LP | Director,TenPercentOwner | P 公開市場買進 | 2.6M | 10.64 | 27.2M | 9.2M | SEC |
| 2024-02-09 | 02-13 | Kolchinsky Peter | Director,TenPercentOwner | P 公開市場買進 | 2.6M | 10.64 | 27.2M | 9.2M | SEC |
| 2024-02-09 | 02-13 | Shah Rajeev M. | Director,TenPercentOwner | P 公開市場買進 | 2.6M | 10.64 | 27.2M | 9.2M | SEC |
| 2024-02-09 | 02-13 | RA Capital Nexus Fund II, L.P. | Director,TenPercentOwner | P 公開市場買進 | 2.6M | 10.64 | 27.2M | 9.2M | SEC |
| 2024-02-09 | 02-13 | RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | P 公開市場買進 | 2.6M | 10.64 | 27.2M | 9.2M | SEC |
| 2023-11-30 | 12-05 | McArthur James G | President and CEO | P 公開市場買進 | 1.7K | 4.17 | 7K | 1.7K | SEC |
| 2023-06-08 | 06-09 | McArthur James G | President and CEO | S 公開市場賣出(10b5-1) | 2.4K | 16.04 | 38K | 0 | SEC |
| 2023-06-08 | 06-09 | McArthur James G | President and CEO | M 選擇權執行 | 2.4K | 2.71 | 6K | 2.4K | SEC |
| 2023-06-07 | 06-08 | McArthur James G | President and CEO | M 選擇權執行 | 8.4K | 2.71 | 23K | 8.4K | SEC |
| 2023-06-07 | 06-08 | McArthur James G | President and CEO | S 公開市場賣出(10b5-1) | 8.4K | 16.23 | 137K | 0 | SEC |
| 2023-06-06 | 06-08 | McArthur James G | President and CEO | S 公開市場賣出(10b5-1) | 18.1K | 16.18 | 294K | 0 | SEC |
| 2023-06-06 | 06-08 | McArthur James G | President and CEO | M 選擇權執行 | 18.1K | 2.71 | 49K | 18.1K | SEC |
| 2023-06-05 | 06-06 | McArthur James G | President and CEO | S 公開市場賣出(10b5-1) | 500 | 16.06 | 8K | 0 | SEC |
| 2023-06-05 | 06-06 | McArthur James G | President and CEO | M 選擇權執行 | 500 | 2.71 | 1K | 500 | SEC |
| 2023-06-02 | 06-06 | McArthur James G | President and CEO | M 選擇權執行 | 1.8K | 2.71 | 5K | 1.8K | SEC |
| 2023-06-02 | 06-06 | McArthur James G | President and CEO | S 公開市場賣出(10b5-1) | 1.8K | 16.04 | 29K | 0 | SEC |
| 2023-03-24 | 03-28 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S 公開市場賣出 | 392 | 20.00 | 8K | 0 | SEC |
| 2023-03-24 | 03-28 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M 選擇權執行 | 392 | 10.88 | 4K | 392 | SEC |
| 2023-02-08 | 02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S 公開市場賣出 | 644 | 17.00 | 11K | 0 | SEC |
| 2023-02-08 | 02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M 選擇權執行 | 644 | 10.88 | 7K | 644 | SEC |
| 2023-02-07 | 02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M 選擇權執行 | 3.7K | 10.88 | 40K | 3.7K | SEC |
| 2023-02-07 | 02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S 公開市場賣出 | 3.7K | 17.18 | 63K | 0 | SEC |
| 2023-02-06 | 02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | M 選擇權執行 | 1.7K | 10.88 | 18K | 1.7K | SEC |
| 2023-02-06 | 02-08 | Goyal Jaya | EVP, Res. & Preclin. Dev. | S 公開市場賣出 | 1.7K | 17.04 | 29K | 0 | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 20.1M | 36.1M | 新進 | 新進 |
| Commodore Capital LP | 4.5M | 8.1M | 新進 | 新進 |
| 維京環球 VIKING GLOBAL INVESTORS LP | 3.5M | 6.3M | 新進 | 新進 |
| Laurion Capital Management LP | 2.8M | 5.0M | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 2.6M | 4.7M | 新進 | 新進 |
| Vivo Capital, LLC | 2.3M | 4.2M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | 3.5M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 1.8M | 3.2M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.5M | 2.7M | 新進 | 新進 |
| BlackRock, Inc. | 1.3M | 2.3M | 新進 | 新進 |
| MARSHALL WACE, LLP | 867K | 1.6M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 658K | 1.2M | 新進 | 新進 |
| AWM Investment Company, Inc. | 600K | 1.1M | 新進 | 新進 |
| MONIMUS CAPITAL MANAGEMENT, LP | 588K | 1.1M | 新進 | 新進 |
| Squarepoint Ops LLC | 529K | 952K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 523K | 943K | 新進 | 新進 |
| Creek Drive Management Group LLC | 450K | 810K | 新進 | 新進 |
| Ikarian Capital, LLC | 447K | 805K | 新進 | 新進 |
| DIADEMA PARTNERS LP | 373K | 672K | 新進 | 新進 |
| BOOTHBAY FUND MANAGEMENT, LLC | 366K | 659K | 新進 | 新進 |
| Rosalind Advisors, Inc. | 350K | 630K | 新進 | 新進 |
| Driehaus Capital Management LLC | 280K | 504K | 新進 | 新進 |
| Boxer Capital Management, LLC | 273K | 491K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 261K | 471K | 新進 | 新進 |
| XTX Topco Ltd | 245K | 442K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 72 -22 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 72 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 52.1M · 75.2% |
| 合計季末市值 | 92.2M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.7M |
|---|---|
| 與上期比 | -15.9% |
| 佔流通股數 | 5.33% |
| 日均成交量 | 678K |
| 回補天數 | 5.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.7M | -15.9% | 5.33% | 678K | 5.5 |
| 2026-08-14 | 4.4M | +6.9% | 6.34% | 1.4M | 3.1 |
| 2026-07-31 | 4.1M | -9.4% | 5.93% | 674K | 6.1 |
| 2026-07-15 | 4.5M | +13.3% | 6.55% | 1.6M | 2.9 |
| 2026-06-30 | 4.0M | +3.8% | 5.78% | 689K | 5.8 |
| 2026-06-15 | 3.9M | +2.9% | 5.56% | 542K | 7.1 |
| 2026-05-29 | 3.7M | +8.1% | 5.41% | 685K | 5.5 |
| 2026-05-15 | 3.5M | +8.1% | 5.00% | 1.0M | 3.4 |
| 2026-04-30 | 3.2M | -10.3% | 4.63% | 804K | 4.0 |
| 2026-04-15 | 3.6M | +3.8% | 5.15% | 1.9M | 1.8 |
| 2026-03-31 | 3.4M | +2.7% | 4.96% | 2.9M | 1.2 |
| 2026-03-13 | 3.3M | +26.1% | 4.83% | 969K | 3.5 |
| 2026-02-27 | 2.7M | -7.0% | 3.83% | 283K | 9.4 |
| 2026-02-13 | 2.9M | +2.7% | 4.12% | 903K | 3.2 |
| 2026-01-30 | 2.8M | +7.6% | 4.01% | 735K | 3.8 |
| 2026-01-15 | 2.6M | -6.5% | 3.73% | 719K | 3.6 |
| 2025-12-31 | 2.8M | +15.7% | 3.99% | 586K | 4.7 |
| 2025-12-15 | 2.4M | +3.7% | 3.45% | 635K | 3.8 |
| 2025-11-28 | 2.3M | +4.3% | 3.32% | 1.1M | 2.2 |
| 2025-11-14 | 2.2M | -4.8% | 3.19% | 514K | 4.3 |
| 2025-10-31 | 2.3M | -41.1% | 3.35% | 759K | 3.1 |
| 2025-10-15 | 3.9M | -23.9% | 5.68% | 1.4M | 2.9 |
| 2025-09-30 | 5.2M | +359.7% | 7.47% | 16.1M | 1.0 |
| 2025-09-15 | 1.1M | -0.8% | 1.62% | 514K | 2.2 |
| 2025-08-29 | 1.1M | -13.4% | 1.64% | 251K | 4.5 |
| 2025-08-15 | 1.3M | +5.0% | 1.89% | 435K | 3.0 |